DCB Treatment in CTO PCI: Insights from PROGRESS‑CTO
We Recommend
Disclosures
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- Consultant Fee/Honoraria/Speaker’s Bureau - Abbott Vascular; Cordis Corporation, a Johnson & Johnson company; Biotronik; Boston Scientific Corporation; CSI; GE Healthcare; Medtronic; Teleflex; Medicure; Asahi; IMDS; Terumo Medical Corporation
- Royalty/Intellectual Property Rights - Elsevier
- Equity/Stock(s)/Options - MHI Ventures; Cleerly Health; Stallion Medical
- - Hippocrates LLC
- Grant Support/Research Contract - Boston Scientific Corporation; GE Healthcare
- Consultant Fee/Honoraria/Speaker's Bureau - Biotronik; Haemonetics